AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes. Dehnad A, Fan W, Jiang JX, Fish SR, et al. J Clin Invest 2020 Jul 13. pii: 133051. doi: 10.1172/JCI133051.

Read + Share

Amedeo Smart

Independent Medical Education

Dehnad A, Fan W, Jiang JX, Fish SR, et al. AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes. J Clin Invest 2020 Jul 13. pii: 133051. doi: 10.1172/JCI133051.
PMID: 32657776